Table 3.
Statins, Beta-Blockers, and ACE Inhibitor medication compliance at one-year, Pharmacist Assisted Compliance Trial, Worcester Massachusetts, 2000–2005 (n = 689).
| Condition | Control (n = 338) | intervention (n = 351) | P-value | ||
|---|---|---|---|---|---|
| Mean (SD) | n | Mean (SD) | n | ||
| Statins | |||||
| Number statin refills | 6.13 (3.7) | 179 | 6.35 (3.8) | 196 | .562 |
| Statin CMA | 0.90 (0.3) | 162 | 0.88 (0.3) | 173 | .509 |
| Number of prescriptions | 2.41 (0.8) | 223 | 2.55 (0.8) | 238 | .078 |
| Total days on statin | 290.53 (94.30) | 179 | 291.20 (92.40) | 196 | .944 |
|
| |||||
| Beta Blockers | |||||
| Number refills | 5.80 (4.0) | 189 | 6.34 (4.0) | 207 | .179 |
| Beta-blocker CMA | 0.91 (0.4) | 157 | 0.97 (1.1) | 180 | .557 |
| Total days on beta-blocker | 283.19 (101.50) | 189 | 287.55 (99.40) | 207 | .667 |
|
| |||||
| ACE Inhibitors | |||||
| Number refills | 5.73 (3.8) | 146 | 6.23 (3.9) | 179 | .247 |
| ACE CMA | 0.93 (0.3) | 126 | 1.02 (0.8) | 157 | .249 |
| Total days on ACE | 280.94 (93.40) | 146 | 283.56 (95.00) | 179 | .803 |
|
| |||||
| % (Frequency) | % (Frequency) | ||||
| Monthlya statin prescription | 69.83 (125) | 179 | 70.41 (138) | 196 | .911 |
| Monthlya beta-blocker prescription | 59.79 (113) | 189 | 64.25 (33) | 207 | .407 |
| Monthlya ACE prescription | 61.64 (90) | 146 | 70.39 (126) | 179 | .1 |
∗a: An indicator of whether all prescriptions for the medication were monthly (or less) prescriptions (versus 90 day or something >30 days at any time).